1-9 of 9
Michael Wang
Close
Sort by
Journal Articles

Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL

Clinical Trials & Observations
Chijioke Nze, Clark R. Andersen, Amy A. Ayers, Jason Westin, Michael Wang, Swaminathan Iyer, Sairah Ahmed, Chelsea Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J. Nastoupil, Kehe Zhang, Cici X. Bauer, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3825–3837.
https://doi.org/10.1182/bloodadvances.2023011040
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma

James N. Gerson, Elizabeth Handorf, Diego Villa, Alina S. Gerrie, Parv Chapani, Shaoying Li, L. Jeffrey Medeiros, Michael Wang, Jonathon B. Cohen, Michael Churnetski, Brian T. Hill, Yazeed Sawalha, Francisco J. Hernandez-Ilizaliturri, Shalin Kothari, Julie M. Vose, Martin Bast, Timothy Fenske, Swapna Narayana Rao Gari, Kami J. Maddocks, David Bond, Veronika Bachanova, Bhaskar Kolla, Julio Chavez, Bijal Shah, Frederick Lansigan, Timothy Burns, Alexandra M. Donovan, Nina Wagner-Johnston, Marcus Messmer, Amitkumar Mehta, Jennifer K. Anderson, Nishitha Reddy, Alexandra E. Kovach, Daniel J. Landsburg, Martha Glenn, David J. Inwards, Kay Ristow, Reem Karmali, Jason B. Kaplan, Paolo F. Caimi, Saurabh Rajguru, Andrew Evens, Andreas Klein, Elvira Umyarova, Bhargavi Pulluri, Jennifer E. Amengual, Jennifer K. Lue, Catherine Diefenbach, Richard I. Fisher, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7393–7401.
https://doi.org/10.1182/bloodadvances.2023010757
Published: 2023
Includes: Supplemental data
Journal Articles

Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma

Yuxuan Che, Yang Liu, Yijing Li, Joseph M. McIntosh, Alexa Jordan, Fangfang Yan, Wei Wang, Lei Nie, Heng-Huan Lee, Jingling Jin, Yixin Yao, Zhongming Zhao, Vivian Changying Jiang, Michael Wang
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3361–3365.
https://doi.org/10.1182/bloodadvances.2022008954
Published: 2023
Includes: Supplemental data
Journal Articles

Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo

Xiaoshan Zhang, Ran Zhang, Chenghui Ren, Yi Xu, Shuhong Wu, Carrie Meng, Apar Pataer, Xingzhi Song, Jianhua Zhang, Yixin Yao, Hua He, Huiqin Chen, Wencai Ma, Jing Wang, Funda Meric-Bernstam, Richard E. Champlin, John V. Heymach, Cliona M. Rooney, Stephen G. Swisher, Ara A. Vaporciyan, Jack A. Roth, M. James You, Michael Wang, Bingliang Fang
Journal: Blood Advances
Blood Adv (2022) 6 (3): 891–901.
https://doi.org/10.1182/bloodadvances.2021006156
Published: 2022
Includes: Supplemental data
Journal Articles

CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity

Clinical Trials & Observations
Uri Greenbaum, Paolo Strati, Rima M. Saliba, Janet Torres, Gabriela Rondon, Yago Nieto, Chitra Hosing, Samer A. Srour, Jason Westin, Luis E. Fayad, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Christopher R. Flowers, Sudhakar Tummala, Jeremy L. Ramdial, Fevzi F. Yalniz, Misha Hawkins, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Sattva S. Neelapu, Partow Kebriaei, Sairah Ahmed
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2799–2806.
https://doi.org/10.1182/bloodadvances.2021004575
Published: 2021
Includes: Supplemental data
Journal Articles

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Clinical Trials & Observations
Constantine S. Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Munoz, Tycel J. Phillips, Won Seog Kim, Simon Rule, Siminder Kaur Atwal, Rachel Wei, William Novotny, Jane Huang, Michael Wang, Judith Trotman
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2577–2585.
https://doi.org/10.1182/bloodadvances.2020004074
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Paolo Strati, Loretta J. Nastoupil, Jason Westin, Luis E. Fayad, Sairah Ahmed, Nathan H. Fowler, Fredrick B. Hagemeister, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Sherry Adkins, Catherine M. Claussen, Charles S. Martinez, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, Haleigh E. Mistry, Sandra Horowitz, Shirley George, Lei Feng, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Sudhakar Tummala, T. Linda Chi
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3943–3951.
https://doi.org/10.1182/bloodadvances.2020002228
Published: 2020
Journal Articles

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Paolo Strati, Penny Fang, Misha C. Hawkins, Sherry Adkins, Jason Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphael E. Steiner, Swaminathan P. Iyer, M. Alma Rodriguez, Michael Wang, Christopher Flowers, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2871–2883.
https://doi.org/10.1182/bloodadvances.2020001837
Published: 2020
Journal Articles

Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma

Clinical Trials & Observations
Matthew S. Ning, Chelsea C. Pinnix, Bhavana V. Chapman, Jillian R. Gunther, Sarah A. Milgrom, Joseph D. Khoury, Preetesh Jain, Wendy Y. Chen, Onyeka N. Oriabure, Maria R. Badillo, L. Michael Wang, Bouthaina S. Dabaja
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2035–2039.
https://doi.org/10.1182/bloodadvances.2019030858
Published: 2019